QUEBEC CITY, Aug. 13 /CNW/ - Medicago Inc. (TSX-V: MDG) today announced that it will be presenting an update of its development of H5N1 vaccines generated from plant-made VLPs and unique technology platform, at the Targeted Immunotherapeutics and Vaccine Summit. This conference will be held from August 13-15, 2008, at the Royal Sonesta Hotel, Cambridge, Massachusetts.
